Answer
With Kymriah (tisagenlecleucel), acute kidney injury is very common (≥1/10), a grouped category including acute kidney injury, anuria, azotaemia, abnormal or increased blood creatinine, increased blood urea, renal failure, renal tubular dysfunction and renal tubular necrosis.
Sources for this answer
- Kymriah cells dispersion for infusionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.8 Undesirable effects · Version 15Document updated
Sources checked